Newbinak Plaster (Pelvinac)
Felbinac 35mg
Patch · OTC medication
(Co., Ltd.) TDS Pharm
MFDS item code 200904679 · Notified 2009.07.01
Relief of joint and muscle pain due to degenerative arthritis
This medication is used effectively to relieve symptoms associated with osteoarthritis such as degenerative arthritis, shoulder periarthritis, inflammation of tendons and surrounding tissues, tennis elbow (lateral epicondylitis), muscle pain, and swelling and pain after trauma.
After removing the release liner from the patch, apply 1 patch to the affected area (location of the disease) twice a day.
This medication should not be used in certain patients. First, individuals who have had an allergic reaction to this medication, its ingredients, and similar Felbinac formulations should avoid its use. Additionally, patients who have experienced asthma attacks while taking aspirin or other non-steroidal anti-inflammatory drugs should refrain from using this medication, as it may worsen asthma symptoms. Patients who have had hives or acute rhinitis symptoms due to aspirin or non-steroidal anti-inflammatory drugs should not use this medication. Patients with bronchial asthma should be cautious when using this medication, as there is a risk of asthma attacks occurring. When using this medication, skin irritation, redness, erythema, rash, eczema, contact dermatitis, and, rarely, feelings of irritation or blisters may occur. If these symptoms are severe, the use of this medication should be discontinued immediately. This medication is a symptomatic treatment for relieving inflammation or pain and is not intended to treat the underlying cause. Applying this medication to areas with skin infections may not reveal the infection's symptoms; therefore, appropriate antibacterial or antifungal medications should be used alongside, and the condition should be closely monitored. When using this for chronic conditions such as degenerative arthritis, other treatment options should also be considered in addition to medication therapy, and the patient's condition and occurrence of side effects need careful monitoring. In late pregnancy, this medication may cause complications such as delivery complications or delayed labor, so it is safer for pregnant women, women who may become pregnant, and breastfeeding women not to use this medication. The safety of this medication in children has not been sufficiently established, so its use is not recommended for them. This medication should not be applied to areas of broken or damaged skin, mucous membranes, nor to areas with eczema or rashes.
Hives, asthma attacks
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in a container that protects it from light. Additionally, when storing the medication, it is important to maintain a room temperature between 1 degree and 30 degrees Celsius. Doing so will help maintain the medication's efficacy and ensure safe use.
This medicine is a transdermal patch coated with a transparent to translucent, adhesive substance and covered with a release liner on a solid surface.
10 sheets/pack
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Felbinac 35mg
Patch · OTC medication
(Co., Ltd.) TDS Pharm
Felbinac 58.5mg
OTC medication
DaeHwa Pharmaceutical Co., Ltd.
Felbinac 35mg
Patch · OTC medication
Shin Shin Pharmaceutical Co., Ltd.
Felbinac 48mg
OTC medication
TDS Pharm Co., Ltd.
Felbinac 35mg
Patch · OTC medication
Hyundai Pharmaceutical Co., Ltd.
Felbinac 35mg
Patch · OTC medication
JW Pharmaceutical Co., Ltd.
Felbinac 35mg
Patch · OTC medication
Boryung Pharmaceutical Co., Ltd.
Felbinac 35mg
Patch · OTC medication
Yuhan Corporation
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.